ATE322249T1 - System zur abgabe einer tobramycin-formulierung - Google Patents
System zur abgabe einer tobramycin-formulierungInfo
- Publication number
- ATE322249T1 ATE322249T1 AT02771857T AT02771857T ATE322249T1 AT E322249 T1 ATE322249 T1 AT E322249T1 AT 02771857 T AT02771857 T AT 02771857T AT 02771857 T AT02771857 T AT 02771857T AT E322249 T1 ATE322249 T1 AT E322249T1
- Authority
- AT
- Austria
- Prior art keywords
- delivery system
- formulation delivery
- tobramycin
- less
- tobramycin formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29223401P | 2001-05-18 | 2001-05-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE322249T1 true ATE322249T1 (de) | 2006-04-15 |
Family
ID=23123791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02771857T ATE322249T1 (de) | 2001-05-18 | 2002-05-17 | System zur abgabe einer tobramycin-formulierung |
Country Status (11)
Country | Link |
---|---|
US (8) | US20030143162A1 (de) |
EP (2) | EP1320355B1 (de) |
JP (2) | JP2004534763A (de) |
AT (1) | ATE322249T1 (de) |
AU (1) | AU2010210026A1 (de) |
CA (1) | CA2447600C (de) |
DE (1) | DE60210402T2 (de) |
DK (1) | DK1320355T3 (de) |
ES (1) | ES2261735T3 (de) |
PT (1) | PT1320355E (de) |
WO (1) | WO2002094217A1 (de) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW465235B (en) | 1998-09-17 | 2001-11-21 | United Video Properties Inc | Electronic program guide with digital storage |
PT1320355E (pt) * | 2001-05-18 | 2006-08-31 | Chiron Corp | Sistema para administracao de uma formulacao de tobramicina |
US20040022740A1 (en) * | 2001-07-10 | 2004-02-05 | Baker William R. | Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
US20030059375A1 (en) * | 2001-08-20 | 2003-03-27 | Transave, Inc. | Method for treating lung cancers |
MXPA04005865A (es) | 2001-12-19 | 2004-09-13 | Nektar Therapeutics | Suministro de aminoglucosidos a los pulmones. |
US7607436B2 (en) * | 2002-05-06 | 2009-10-27 | The Research Foundation Of State University Of New York | Methods, devices and formulations for targeted endobronchial therapy |
US7334580B2 (en) * | 2002-05-07 | 2008-02-26 | Smaldone Gerald C | Methods, devices and formulations for targeted endobronchial therapy |
WO2004054499A2 (en) * | 2002-08-02 | 2004-07-01 | Transave, Inc. | Platinum aggregates and process for producing the same |
US9186322B2 (en) * | 2002-08-02 | 2015-11-17 | Insmed Incorporated | Platinum aggregates and process for producing the same |
AU2002953095A0 (en) * | 2002-11-29 | 2002-12-19 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
EP3738591A3 (de) * | 2003-03-10 | 2021-03-24 | Merck Sharp & Dohme Corp. | Neuartige antibakterielle wirkstoffe |
US20070071686A1 (en) * | 2003-10-15 | 2007-03-29 | Pari Gmbh | Liquid preparation containing tobramycin |
WO2005089448A2 (en) * | 2004-03-18 | 2005-09-29 | Transave, Inc. | Administration of cisplatin by inhalation |
US20070065522A1 (en) * | 2004-03-18 | 2007-03-22 | Transave, Inc. | Administration of high potency platinum compound formulations by inhalation |
DE602005025754D1 (de) | 2004-05-17 | 2011-02-17 | Corus Pharma Inc | Kombination aus fosfomycin/aminoglycosid in aerosolform zur behandlung bakterieller atemwegsinfektionen |
US20060034906A1 (en) * | 2004-05-21 | 2006-02-16 | Transave, Inc. | Treatment of lung diseases and pre-lung disease conditions |
US20080214481A1 (en) | 2004-06-18 | 2008-09-04 | Novartis Vaccines And Diagnostics, Inc. | Methods of Treatment of Endobronchial Infections |
AU2005306802A1 (en) * | 2004-11-08 | 2006-05-26 | Transave, Inc. | Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally |
CN104586868A (zh) | 2005-09-29 | 2015-05-06 | 尼克塔治疗公司 | 抗生素制剂、单位剂量、试剂盒以及方法 |
AU2013206401B2 (en) * | 2005-09-29 | 2016-06-23 | Novartis Ag | Antibiotic formulations, unit doses, kits, and methods |
US9107824B2 (en) | 2005-11-08 | 2015-08-18 | Insmed Incorporated | Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally |
US20070190181A1 (en) * | 2005-11-08 | 2007-08-16 | Pilkiewicz Frank G | Methods of treating cancer with lipid-based platinum compound forumulations administered intravenously |
WO2007056263A2 (en) * | 2005-11-08 | 2007-05-18 | Transave, Inc. | Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously |
WO2007056264A2 (en) * | 2005-11-08 | 2007-05-18 | Transave, Inc. | Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally |
WO2007064658A2 (en) * | 2005-11-30 | 2007-06-07 | Transave, Inc. | Safe and effective methods of administering therapeutic agents |
PT1962805T (pt) | 2005-12-08 | 2016-10-05 | Insmed Inc | Composições de anti-infeciosos baseadas em lípidos para tratamento de infeções pulmonares |
US8337814B2 (en) * | 2005-12-15 | 2012-12-25 | Topical Sinus Therapeutics, Inc. | Treatment of active infections, sinusitis, rhinitis, and related neurological disorders and related compositions |
JP2008199905A (ja) * | 2007-02-16 | 2008-09-04 | Snow Brand Milk Prod Co Ltd | 乳酸菌生残性向上剤 |
WO2009055557A1 (en) | 2007-10-25 | 2009-04-30 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
US20110049634A1 (en) * | 2008-04-02 | 2011-03-03 | Nxp B.V. | Method of manufacturing a semiconductor device and semiconductor device |
ES2565083T3 (es) * | 2008-10-24 | 2016-03-31 | Cempra Pharmaceuticals, Inc. | Biodefensas usando macrólidos que contienen triazol |
US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
JP5914335B2 (ja) | 2009-09-10 | 2016-05-11 | センプラ ファーマシューティカルズ,インコーポレイテッド | マラリア、結核、及びmac病の治療方法 |
MY162411A (en) | 2010-03-22 | 2017-06-15 | Cempra Pharmaceuticals Inc | Crystalline forms of a macrolide, and uses therefor |
SI2571506T1 (sl) | 2010-05-20 | 2017-12-29 | Cempra Pharmaceuticals, Inc. | Postopki za pripravo makrolidov in ketolidov ter njihovih intermediatov |
WO2012007130A1 (en) * | 2010-07-12 | 2012-01-19 | Xellia Pharmaceuticals Aps | Treatment of lung infections by administration of tobramycin by aerolisation |
KR20130120458A (ko) | 2010-09-10 | 2013-11-04 | 셈프라 파마슈티컬스, 인크. | 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드 |
US8826904B2 (en) | 2011-07-12 | 2014-09-09 | Cardeas Pharma Corporation | Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis |
RU2014101763A (ru) | 2011-07-12 | 2015-08-20 | Кардис Фарма Корпорейшн | Композиции комбинаций амикацина и фосфомицина, способы и системы для лечения вентилятор-ассоциированной пневмонии и вентилятор-ассоциированного трахеоброхита |
CA2868262A1 (en) | 2012-03-27 | 2013-10-03 | Cempra Pharmaceuticals, Inc. | Parenteral formulations for administering macrolide antibiotics |
GB201208080D0 (en) | 2012-05-09 | 2012-06-20 | Norton Healthcare Ltd | Tobramycin formulation |
CN105025904A (zh) | 2012-09-04 | 2015-11-04 | 埃莱森制药有限责任公司 | 用顺铂脂质复合物预防癌症的肺部复发 |
RU2018135921A (ru) | 2012-11-29 | 2019-02-05 | Инсмед Инкорпорейтед | Стабилизированные составы ванкомицина |
SI2943503T1 (sl) | 2013-01-11 | 2017-11-30 | Xellia Pharmaceuticals Aps | Polimiksini, sestava, postopki priprave in postopki uporabe |
AU2014239959A1 (en) * | 2013-03-14 | 2015-10-01 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
JP6675973B2 (ja) | 2013-03-15 | 2020-04-08 | センプラ ファーマシューティカルズ,インコーポレイテッド | マクロライド抗菌薬を調製するための集束的な方法 |
DK3142643T3 (da) * | 2014-05-15 | 2019-10-14 | Insmed Inc | Fremgangsmåder til behandling af ikke-tuberkuløse mykobakterielle lungeinfektioner |
CN106661090A (zh) | 2014-07-09 | 2017-05-10 | 埃克斯利亚制药有限公司 | 低取代的多粘菌素以及它们的组合物 |
US10532080B2 (en) | 2014-10-03 | 2020-01-14 | Xellia Pharmaceuticals Aps | Sulfomethylated polymixin compositions |
DK3200762T3 (da) | 2014-10-03 | 2019-05-06 | Xellia Pharmaceuticals Aps | Inhalationsanordning |
US10617703B2 (en) | 2014-12-10 | 2020-04-14 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
US11793783B2 (en) | 2015-08-05 | 2023-10-24 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
US11690815B2 (en) | 2015-08-05 | 2023-07-04 | Cmpd Licensing Llc | Hyperkeratotic skin condition treatments and compositions |
US11446236B2 (en) | 2015-08-05 | 2022-09-20 | Cmpd Licensing, Llc | Topical antimicrobial compositions and methods of formulating the same |
US10898491B2 (en) | 2015-12-18 | 2021-01-26 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
US11278590B2 (en) | 2015-08-05 | 2022-03-22 | Cmpd Licensing, Llc | Compositions and methods for treating nail infections |
US11684567B2 (en) | 2015-08-05 | 2023-06-27 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
US10898455B2 (en) | 2016-01-07 | 2021-01-26 | Cmpd Licensing, Llc | Urea cream formulations |
US10525025B2 (en) | 2016-11-17 | 2020-01-07 | Cmpd Licensing, Llc | Compounded compositions and methods for treating pain |
US9999604B2 (en) | 2016-11-17 | 2018-06-19 | Cmpd Licensing, Llc | Compounded solutions of diclofenac and lidocaine and methods |
JP7460534B2 (ja) | 2018-03-30 | 2024-04-02 | インスメッド インコーポレイテッド | リポソーム医薬品の連続製造方法 |
WO2020163416A1 (en) * | 2019-02-05 | 2020-08-13 | Mylan Inc | Devices and methods for tobramycin inhalation treatment |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3993223A (en) | 1974-07-25 | 1976-11-23 | American Home Products Corporation | Dispensing container |
US4502616A (en) | 1982-01-04 | 1985-03-05 | Health Care Concepts, Inc. | Single use vial |
GB8801655D0 (en) | 1988-01-26 | 1988-02-24 | Waverley Pharma Ltd | Ampoules |
ES2038445T3 (es) | 1988-01-28 | 1993-07-16 | Lameplast S.R.L. | Tiras de ampollas para productos farmaceuticos, cosmeticos y otros. |
GB8802349D0 (en) | 1988-02-03 | 1988-03-02 | Waverley Pharma Ltd | Ampoule with luer |
DE3916840A1 (de) | 1988-09-21 | 1990-03-29 | Bernd Hansen | Ampulle |
US5409125A (en) | 1989-12-11 | 1995-04-25 | Aktiebolaget Astra | Unit dose container |
CA2027690A1 (en) | 1990-10-18 | 1992-04-19 | Christian Laing | Plastic ampul |
FR2687066A1 (fr) | 1992-02-06 | 1993-08-13 | Oreal | Ampoule autocassable. |
US5508269A (en) * | 1994-10-19 | 1996-04-16 | Pathogenesis Corporation | Aminoglycoside formulation for aerosolization |
US5758637A (en) * | 1995-08-31 | 1998-06-02 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US6083922A (en) | 1996-04-02 | 2000-07-04 | Pathogenesis, Corp. | Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis |
AU778797B2 (en) | 1998-12-17 | 2004-12-23 | Novartis Vaccines And Diagnostics, Inc. | Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic |
SE9902627D0 (sv) * | 1999-07-08 | 1999-07-08 | Siemens Elema Ab | Medical nebulizer |
DE19953317C1 (de) | 1999-11-05 | 2001-02-01 | Pari Gmbh | Inhalationsvernebler |
PT1320355E (pt) | 2001-05-18 | 2006-08-31 | Chiron Corp | Sistema para administracao de uma formulacao de tobramicina |
-
2002
- 2002-05-17 PT PT02771857T patent/PT1320355E/pt unknown
- 2002-05-17 DK DK02771857T patent/DK1320355T3/da active
- 2002-05-17 JP JP2002590936A patent/JP2004534763A/ja active Pending
- 2002-05-17 WO PCT/US2002/015999 patent/WO2002094217A1/en active IP Right Grant
- 2002-05-17 AT AT02771857T patent/ATE322249T1/de active
- 2002-05-17 EP EP02771857A patent/EP1320355B1/de not_active Revoked
- 2002-05-17 EP EP09015943A patent/EP2186508A3/de not_active Withdrawn
- 2002-05-17 DE DE60210402T patent/DE60210402T2/de not_active Revoked
- 2002-05-17 ES ES02771857T patent/ES2261735T3/es not_active Expired - Lifetime
- 2002-05-17 CA CA2447600A patent/CA2447600C/en not_active Expired - Fee Related
- 2002-05-17 US US10/151,701 patent/US20030143162A1/en not_active Abandoned
-
2003
- 2003-12-22 US US10/743,529 patent/US6890907B2/en not_active Expired - Lifetime
-
2004
- 2004-07-01 US US10/883,143 patent/US20040265241A1/en not_active Abandoned
-
2005
- 2005-05-10 US US11/126,108 patent/US20050201947A1/en not_active Abandoned
- 2005-05-10 US US11/125,670 patent/US20050207987A1/en not_active Abandoned
-
2007
- 2007-10-24 US US11/923,486 patent/US7825095B2/en not_active Expired - Lifetime
-
2009
- 2009-08-07 JP JP2009185305A patent/JP2009269923A/ja active Pending
-
2010
- 2010-08-09 AU AU2010210026A patent/AU2010210026A1/en not_active Abandoned
- 2010-09-17 US US12/884,505 patent/US20110005518A1/en not_active Abandoned
-
2011
- 2011-11-14 US US13/295,228 patent/US8507454B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1320355B1 (de) | 2006-04-05 |
DE60210402T2 (de) | 2006-12-07 |
US20080095717A1 (en) | 2008-04-24 |
US20030143162A1 (en) | 2003-07-31 |
US20040131555A1 (en) | 2004-07-08 |
PT1320355E (pt) | 2006-08-31 |
CA2447600C (en) | 2015-10-20 |
US8507454B2 (en) | 2013-08-13 |
JP2009269923A (ja) | 2009-11-19 |
US7825095B2 (en) | 2010-11-02 |
AU2010210026A1 (en) | 2010-09-02 |
US20050207987A1 (en) | 2005-09-22 |
US20040265241A1 (en) | 2004-12-30 |
WO2002094217A1 (en) | 2002-11-28 |
US20110005518A1 (en) | 2011-01-13 |
US20050201947A1 (en) | 2005-09-15 |
US20120101055A1 (en) | 2012-04-26 |
EP2186508A3 (de) | 2010-08-25 |
EP1320355A1 (de) | 2003-06-25 |
DE60210402D1 (de) | 2006-05-18 |
EP2186508A2 (de) | 2010-05-19 |
JP2004534763A (ja) | 2004-11-18 |
CA2447600A1 (en) | 2002-11-28 |
ES2261735T3 (es) | 2006-11-16 |
DK1320355T3 (da) | 2006-07-31 |
US6890907B2 (en) | 2005-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE322249T1 (de) | System zur abgabe einer tobramycin-formulierung | |
WO2002043750A3 (en) | Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations | |
BR0108730A (pt) | Sistema, dispositivo e método para administração de uma droga, bocal de um dispositivo de administração de droga, dispositivo para administração de doses unitárias múltiplas de uma droga, métodos para preparação de um sistema de administração de droga e de uma formulação de droga e para tratamento de um paciente que necessita de doses múltiplas de uma droga, formulação de droga e multiparticulados | |
NZ552047A (en) | Method of treatment of endobronchial infections | |
IL139231A0 (en) | Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract | |
BR0109875A (pt) | Tratamento de doenças respiratórias | |
EP0861667A3 (de) | Partikelförmige Mittel | |
EP3268010B1 (de) | Zusammensetzungen aus gesäuertem nitrit, einem eisen-chelator und einem antibakteriellen wirkstoff zur behandlung von bakterieninfektionen | |
MXPA03000353A (es) | Medicamentos para tratamiento quimioterapeutico de enfermedades. | |
IL101056A (en) | Composition for nasal treatment | |
MY144021A (en) | Pharmaceutical delivery system | |
AU644094B2 (en) | Medicaments | |
MXPA03000321A (es) | Formulaciones de macrolido para inhalacion y metodos de tratamiento de infecciones endobronquiales. | |
MXPA05009629A (es) | Composiciones que contienen trospio. | |
BR9812553A (pt) | Formulação medicamentosa com liberação de substância ativa controlada | |
DK98089D0 (da) | Medikament-lipid-systemer med lav toxicitet | |
WO2005037256A3 (de) | Flüssige zubereitung enthaltend tobramycin | |
WO2005044186A3 (en) | Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same | |
NO20041011L (no) | Inhaleringssammensetninger omfattende tricykliske 5,6-dihydro-9H-pyrazolo(3,4-C) -1,2,4-triazolo(4,3-alfa)pyridiner | |
AU2615795A (en) | Compounds and compositions for administration via oral inhalation or insufflation | |
AU2002236587A1 (en) | Compositions for adhesion prevention | |
WO2002074287A3 (en) | Antibacterial compositions containing of oxapenem-3-carboxylic acids and antibiotics | |
EP0753309A2 (de) | Lactoferrin (oder analoge Proteine) und Desferrioxamine-Methansulfonate (oder andere Metalionenchelaten) Zusammensetzung für Therapie von viralen infektiösen Krankheiten | |
ATE284696T1 (de) | Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten | |
KR20090042507A (ko) | 돼지 위축성 비염의 예방 및 치료를 위해 아미카신 및 이의약제학적으로 허용가능한 염과, 베타-글루칸을 유효성분을포함하는 비강 분무용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1320355 Country of ref document: EP |